In the past several years, the importance of microRNA (miRNA) in cancer cells has been recognized. Proper control of miRNA expression is essential for maintaining a steady state of the cellular machinery. Recently, it was discovered that extracellular miRNAs circulate in the blood of both healthy and diseased patients, although ribonuclease is present in both…
Cancer Science Template
Write in a clean editor, then format for Cancer Science in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Cancer Science format
Cancer Science is a peer-reviewed journal published by Wiley, covering RNA modifications and cancer, Epigenetics and DNA Methylation, Cancer Cells and Metastasis.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Cancer Science 12 (3): 45–58.
Formats any DOI in Cancer Science style. No sign-up. |
| Publishes research in | RNA modifications and cancer Epigenetics and DNA Methylation Cancer Cells and Metastasis Cancer-related molecular mechanisms research Cancer Immunotherapy and Biomarkers |
| ISSN | 1347-9032 |
| Citation impact (2-yr) | 3.97 |
| h-index | 186 |
| i10-index | 5,657 |
| Total citations | 305,110 |
| Article processing charge | $2,250 |
| Open access | Yes |
| Top institutions publishing here | The University of Tokyo |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Cancer Science per year
Citation impact of Cancer Science by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Cancer Science
Regulatory T (Treg) cells suppress abnormal/excessive immune responses to self- and nonself-antigens to maintain immune homeostasis. In tumor immunity, Treg cells are involved in tumor development and progression by inhibiting antitumor immunity. There are several Treg cell immune suppressive mechanisms: inhibition of costimulatory signals by CD80 and CD86 expressed by dendritic cells through cytotoxic T-lymphocyte…
Reactive oxygen species (ROS), a class of highly bioactive molecules, have been widely studied in various types of cancers. ROS are considered to be normal byproducts of numerous cellular processes. Typically, cancer cells exhibit higher basal levels of ROS compared with normal cells as a result of an imbalance between oxidants and antioxidants. ROS have…
Epithelial-mesenchymal transition (EMT) describes the differentiation switch between polarized epithelial cells and contractile and motile mesenchymal cells, and facilitates cell movements and generation of new tissue types during embryogenesis. Many secreted polypeptides are implicated in the EMT process and their corresponding intracellular transduction pathways form highly interconnected networks. Transforming growth factor-beta, Wnt, Notch and growth…
The epithelial-mesenchymal transition (EMT) plays a critical role in embryonic development. EMT is also involved in cancer progression and metastasis and it is probable that a common molecular mechanism is shared by these processes. Cancer cells undergoing EMT can acquire invasive properties and enter the surrounding stroma, resulting in the creation of a favorable microenvironment…